of physiological or

pharmacological inhibitors can thus be envisaged. Roscovitine (ROS), as a selective

cdc2 inhibitor, has been reported to inhibit MPF and MAP kinase activity and

maintains the oocyte at Germinal Vesicle (GV) stage. The aim...